Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Delcath Receives Notice of European Regulatory Approval for Hepatic CHEMOSATâ„¢ Delivery System

April 13, 2011 By Bio-Medicine.Org

NEW YORK, April 13, 2011 /PRNewswire/ — Delcath Systems, Inc.
(NASDAQ:
DCTH
) today announced that the Company has been notified of CE
Mark approval for its proprietary Hepatic CHEMOSAT™ Delivery
System. The product has been approved with an indication for the
percutaneous intra-arterial administration of a chemotherapeutic
agent (melphalan hydrochloride) to the liver.

CE Marking confirms that a medical device complies with the
Essential Requirements of the Medical Device Directive, and that
the device has been subjected to conformity assessment procedures.
Receipt of the CE Mark allows Delcath to market and sell the
product in countries in the European Economic Area.

“Receipt of our CE Mark represents the first regulatory approval
for this product, and marks the beginning of the Company’s
transition into a fully commercial enterprise,” said Eamonn P.
Hobbs, CEO & President of Delcath Systems. “With its rising
liver cancer rates, Europe represents a large opportunity for this
product. We believe the Hepatic CHEMOSAT Delivery System may
ultimately fulfill an annual unmet clinical need for as many as
100,000 liver cancer patients in this region.  With the CE
Mark in hand, we will now begin to build inventory and establish
the commercialization infrastructure in Europe, including
assembling a direct sales organization to cover countries in
Northern Europe and establishing a network of third party
distributors in Southern Europe. We will also begin establishing
and training initial sites in select European countries as Centers
of Clinical Excellence for the chemosaturation procedure.”

About Delcath SystemsDelcath Systems, Inc. is a
specialty pharmaceutical and medical device company focused on
oncology. Delcath’s proprietary system for chemosaturation is
designed to administer high dose chemotherapy and other therapeutic
agents to diseased o

‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech